Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 80
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Nano Lett ; 24(9): 2861-2869, 2024 Mar 06.
Article in English | MEDLINE | ID: mdl-38408922

ABSTRACT

Advanced portable healthcare devices with high efficiencies, small pressure drops, and high-temperature resistance are urgently desired in harsh environments with high temperatures, high humidities, and high levels of atmospheric pollution. Triboelectric nanogenerators (TENGs), which serve as energy converters in a revolutionary self-powered sensor device, present a sustainable solution for meeting these requirements. In this work, we developed a porous negative triboelectric material by synthesizing ZIF-8 on the surface of a cellulose/graphene oxide aerogel, grafting it with trimethoxy(1H,1H,2H,2H-heptadecafluorodecyl)silane, and adding a negative corona treatment, and it was combined with a positive triboelectric material to create a cellulose nanofiber-based TENG self-powered filter. The devices achieved a balance between a small pressure drop (53 Pa) and high filtration efficiency (98.97%, 99.65%, and 99.93% for PM0.3, PM0.5, and PM1, respectively), demonstrating robust filtration properties at high temperatures and high humidities. Our work provides a new approach for developing self-powered wearable healthcare devices with excellent air filtration properties.

2.
Langmuir ; 2024 Sep 10.
Article in English | MEDLINE | ID: mdl-39254061

ABSTRACT

With the continuous exploitation of petroleum resources, the distribution and displacement of residual oils have become key issues in enhancing oil recovery. In a reservoir, there are various forms of residual oils caused by the capillary force, viscous force, and some other hydrodynamic effects, which lead to the Jamin effect, and they restrict the oil displacement process. In this study, the morphologies of oil droplets in a capillary tube laden with water and sodium dodecyl sulfate (SDS) solutions are experimentally investigated. The pinning behavior of the oil droplet is observed in the waterflood with a lower velocity, while depinning and rupturing behaviors occur at a higher velocity. Hereto, we build a mechanics model to analyze the evolution of the Jamin effect in a capillary tube with varying cross sections. Using this theoretical model, we obtain the two critical velocities for the depinning and rupture of the oil droplet, which agree with the experimental results. Moreover, we find that oil droplets can more easily pass through the entire capillary tube in SDS solutions compared with water. The time required for oil droplets to pass through the pore throat becomes shorter with the increase of SDS concentration. Therefore, a theoretical model is established to determine the total pressure difference and the minimum applied pressure difference. These findings are beneficial to obtain a deep insight into the detailed oil displacement and achieve a higher oil recovery rate.

3.
Langmuir ; 38(38): 11666-11674, 2022 Sep 27.
Article in English | MEDLINE | ID: mdl-36097700

ABSTRACT

Morphologies of evaporative deposition, which has been widely applied in potential fields, were induced by the competition between internal flows inside evaporating droplets. Controlling the pattern of deposition and suppressing the coffee-ring effect are essential issues of intense interest in the aspects of industrial technologies and scientific applications. Here, evaporative deposition of surfactant-laden nanofluid droplets over silicon was experimentally investigated. A ring-like deposition was formed after complete evaporation of sodium dodecyl sulfate (SDS)-laden nanofluid droplets with an initial SDS concentration ranging from 0 to 1.5 CMC. In the case of initial SDS concentrations above 1.3 CMC, no cracks were observed in the ring-like deposition, indicating that the deposition patterns of nanofluid droplets could be completely changed and cracks could be eliminated by sufficient addition of SDS. With the increase of the initial concentration of hexadecyl trimethylammonium bromide (CTAB), the width of the deposition ring gradually decreased until no ring-like structure was formed. On the contrary, with the increase of the initial Triton X-100 (TX-100) concentration, the width of the deposition ring gradually increased until a uniform deposition was generated. Moreover, when the initial TX-100 concentration was high, a "tree-ring-like" pattern was discovered. Besides, morphologies of evaporative pattern due to the addition of surfacants were qualitatively analyzed.

4.
Exp Parasitol ; 238: 108230, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35151652

ABSTRACT

Resistance of Haemonchus contortus to ivermectin has become an increasingly serious problem worldwide. Drug-based control and management of this parasite requires reliable methods for testing drug resistance to evaluate and monitor their anthelmintic effects. In this study, the larval migration inhibition test (LMIT) and the larval feeding inhibition test (LFIT) were used to assess and compare seven strains of H. contortus, including one resistant and one susceptible strain from abroad (UKR and ASS, respectively), and five strains native to China (SXS, WMR, WSR1, WSR2, and WSR3). LFIT results showed that fluorescent-labeled Escherichia coli could be clearly observed after ivermectin (IVM) treatment inside UKR, WMR, WSR1, WSR2, and WSR3 larvae, but not inside ASS and SXS strains. Moreover, LMIT results showed that migration of SXS strain did not change significantly after IVM treatment compared with the susceptible ASS strain, whereas migration increased significantly in the UKR, WMR, WSR1, WSR2, and WSR3 strains. Taken together, SXS was found to be an IVM-susceptible strain, whereas WMR, WSR1, WSR2, and WSR3 were IVM-resistant strains. These results demonstrate that assessment of the motility and feeding ability of H. contortus larvae can be effectively used to determine resistance of H. contortus to IVM.


Subject(s)
Anthelmintics , Haemonchiasis , Haemonchus , Sheep Diseases , Animals , Anthelmintics/pharmacology , Anthelmintics/therapeutic use , Drug Resistance , Haemonchiasis/drug therapy , Haemonchiasis/veterinary , Ivermectin/pharmacology , Ivermectin/therapeutic use , Larva , Sheep , Sheep Diseases/parasitology
5.
J Nanobiotechnology ; 19(1): 251, 2021 Aug 21.
Article in English | MEDLINE | ID: mdl-34419071

ABSTRACT

BACKGROUND: Glioblastoma is a lethal neoplasm with few effective therapy options. As a mainstay in the current treatment of glioma at present, chemotherapeutic agents usually show inadequate therapeutic efficiency due to their low blood brain barrier traversal and brain targeting, together with tumor multidrug resistance. Novel treatment strategies are thus urgently needed to improve chemotherapy outcomes. RESULTS: Here, we report that nanomedicines developed by functionalizing the neurotropic rabies virus-derived polypeptide, RVG, and loading reduction-sensitive nanomicelles (polymer and doxorubicin) enable a highly specific and efficacious drug accumulation in the brain. Interestingly, curcumin serves as the hydrophobic core of the polymer, while suppressing the major efflux proteins in doxorubicin-resistant glioma cells. Studies on doxorubicin-resistant rat glioma cells demonstrate that the RVG-modified micelles exhibit superior cell entry and antitumor activity. In vivo research further showed that RVG modified nanomicelles significantly enhanced brain accumulation and tumor inhibition rate in mice, leading to a higher survival rate with negligible systemic toxicity. Moreover, effective suppression of recurrence and pulmonary metastatic nodules were also determined after the RVG-modified nanomicelles treatment. CONCLUSIONS: The potential of RVG-modified nanomicelles for glioma was demonstrated. Brain accumulation was markedly enhanced after intravenous administration. This unique drug delivery nanoplatform to the brain provides a novel and powerful therapeutic strategy for the treatment of central nervous system disorders including glioma.


Subject(s)
Brain/metabolism , Doxorubicin/administration & dosage , Doxorubicin/metabolism , Micelles , Animals , Antineoplastic Agents , Biocompatible Materials , Brain Neoplasms/drug therapy , Cell Survival , Drug Delivery Systems , Drug Resistance, Multiple/drug effects , Glioblastoma , Glioma/pathology , Mice, Inbred BALB C , Mice, Nude , Particle Size , Peptides/metabolism , Rats
6.
J Nanobiotechnology ; 19(1): 57, 2021 Feb 25.
Article in English | MEDLINE | ID: mdl-33632266

ABSTRACT

BACKGROUND: Lung cancer is the most common type of tumour worldwide. Its relative lethality is considerably high. However, since the tumour tissues are located deep within the human body, traditional technologies, such as photodynamic therapy, do not have the desired effect. Sonosensitisers can penetrate deeply into tissues, and sonodynamic therapy (SDT) effectively inhibits tumours by generating reactive oxygen species. Ultrasound can also penetrate deeply, with a favourable tumour inhibition effect. RESULTS: A redox/ultrasound-responsive Rhein-chondroitin sulphate-based nano-preparation encapsulating docetaxel was fabricated. The nanoparticles displayed increased cellular uptake with quick drug release, good stability, and a monodispersed form in the physiological environment. Rhein induced apoptosis and altered mitochondrial membrane potential, which enhanced the expression of apoptosis-related proteins. SDT inhibited the metastasis and angiogenesis of cancer cells and activated anti-tumour capacity by reducing the expression of M2 macrophages. CONCLUSIONS: The potential of Rhein for SDT was demonstrated. Production of reaction oxygen species was markedly enhanced after ultrasound treatment. The nanoplatform enhanced the synergistic anti-tumour effects of SDT and chemotherapeutic efficacy. The approach was biocompatibility. The findings could inform investigations of chemo-SDT for different cancers.


Subject(s)
Combined Modality Therapy/methods , Drug Therapy/methods , Lung Neoplasms/drug therapy , Polymers/pharmacology , Ultrasonic Therapy/methods , A549 Cells , Anthraquinones , Apoptosis/drug effects , Cell Line, Tumor , Docetaxel/pharmacology , Drug Liberation , Drug Therapy, Combination , Humans , Macrophages/metabolism , Membrane Potential, Mitochondrial/drug effects , Nanoparticles , Reactive Oxygen Species/metabolism
7.
J Nanobiotechnology ; 19(1): 428, 2021 Dec 19.
Article in English | MEDLINE | ID: mdl-34923976

ABSTRACT

Molybdenum oxide (MoOx) nanosheets have drawn increasing attention for minimally invasive cancer treatments but still face great challenges, including complex modifications and the lack of efficient accumulation in tumor. In this work, a novel multifunctional degradable FA-BSA-PEG/MoOx nanosheet was fabricated (LA-PEG and FA-BSA dual modified MoOx): the synergistic effect of PEG and BSA endows the nanosheet with excellent stability and compatibility; the FA, a targeting ligand, facilitates the accumulation of nanosheets in the tumor. In addition, DTX, a model drug for breast cancer treatment, was loaded (76.49%, 1.5 times the carrier weight) in the nanosheets for in vitro and in vivo antitumor evaluation. The results revealed that the FA-BSA-PEG/MoOx@DTX nanosheets combined photothermal and chemotherapy could not only inhibit the primary tumor growth but also suppress the distant tumor growth (inhibition rate: 51.7%) and lung metastasis (inhibition rate: 93.6%), which is far more effective compared to the commercial Taxotere®. Exploration of the molecular mechanism showed that in vivo immune response induced an increase in positive immune responders, suppressed negative immune suppressors, and established an inflammatory tumor immune environment, which co-contributes towards effective suppression of tumor and lung metastasis. Our experiments demonstrated that this novel multifunctional nanosheet is a promising platform for combined chemo-photothermal therapy.


Subject(s)
Biocompatible Materials/chemistry , Breast Neoplasms/drug therapy , Lung Neoplasms/drug therapy , Molybdenum/chemistry , Nanostructures/therapeutic use , Oxides/chemistry , Animals , Biocompatible Materials/pharmacokinetics , Biocompatible Materials/pharmacology , Biocompatible Materials/therapeutic use , Breast Neoplasms/pathology , Cell Line, Tumor , Cell Survival/drug effects , Doxorubicin/chemistry , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , Female , Folic Acid/chemistry , Humans , Hyperthermia, Induced , Infrared Rays , Lung Neoplasms/secondary , Lung Neoplasms/therapy , Mice , Mice, Inbred BALB C , Nanostructures/chemistry , Nanostructures/toxicity , Polyethylene Glycols/chemistry , Serum Albumin, Bovine/chemistry , Thioctic Acid/chemistry , Tissue Distribution
8.
Parasitology ; 147(13): 1509-1514, 2020 11.
Article in English | MEDLINE | ID: mdl-32741381

ABSTRACT

Parabronema skrjabini is one of the most harmful nematodes to camels and is responsible for economic losses in animal husbandry industry. There is an urgent need for in-depth studies of potential vectors of the nematode due to its scant regarding information. As previous studies indicated that flies may be the vectors of P. skrjabini, we captured flies in the main camel-producing areas of Inner Mongolia. After autopsy of the specimens of two species of horn flies, we observed the morphology of the suspected nematode larvae found in them. Internal transcribed spacer ribosomal-DNA gene sequences were considered the best candidate to confirm the species of the larvae found. Our results showed that the homology compared with P. skrjabini was 99.5% in GenBank. Subsequently, we preliminarily identified two species of horn flies through morphological observation and then sequenced the mitochondrial-DNA-gene cytochrome oxidase subunit I obtained from two species of horn flies, with 100 and 99.2% similarity to sequences deposited in GenBank, respectively. Thus, we identified Haematobia titillans and Haematobia irritans and provided evidence for their potential role as vectors of parabronemosis. Our study provides reference for future research on the life history of the nematode and the vectors of parabronemosis.


Subject(s)
Camelus , Insect Vectors/parasitology , Muscidae/parasitology , Spirurida Infections/veterinary , Spiruroidea/physiology , Animals , China , Larva/growth & development , Larva/physiology , Spirurida Infections/parasitology , Spirurida Infections/transmission , Spiruroidea/growth & development
9.
Int J Mol Sci ; 20(18)2019 Sep 17.
Article in English | MEDLINE | ID: mdl-31533205

ABSTRACT

We present the evaluation of a sulfoxide-based polymer (poly(propylene sulfoxide), PPSO) as a potential 'stealth' macromolecule, and at the same time as a pharmacologically active (anti-inflammatory/anti-oxidant) material. The combination of these two concepts may at first seem peculiar since the gold standard polymer in biomaterials and drug delivery, poly(ethylene glycol) (PEG), is 'stealth' due to its chemical and biological inertness, which makes it hardly biologically active. Polysulfoxides, on the contrary, may couple a substantial inertness towards biomolecules under homeostatic conditions, with the possibility to scavenge reactive oxygen species (ROS) associated to inflammation. Polysulfoxides, therefore, are rather uniquely, 'active' 'stealth' polymers. Here, we describe the synthesis of PPSO through controlled oxidation of poly(propylene sulfide) (PPS), which on its turn was obtained via anionic ring-opening polymerization. In vitro, PPSO was characterized by a low toxicity (IC50 ~7 mg/mL at 24 h on human dermal fibroblasts) and a level of complement activation (in human plasma) and macrophage uptake slightly lower than PEG of a similar size. Importantly, and differently from PEG, on LPS-activated macrophages, PPSO showed a strong and dose-dependent ROS (hydrogen peroxide and hypochlorite)-scavenging activity, which resulted in a corresponding reduction of cytokine production.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antioxidants/pharmacology , Biopolymers/pharmacology , Sulfoxides/pharmacology , Animals , Anti-Inflammatory Agents/chemistry , Antioxidants/chemistry , Biopolymers/chemistry , Cell Survival/drug effects , Chemical Phenomena , Fibroblasts , Humans , Mice , Molecular Structure , Molecular Weight , Polymerization , RAW 264.7 Cells , Reactive Oxygen Species/metabolism , Sulfoxides/chemistry
10.
Biomacromolecules ; 16(2): 423-36, 2015 Feb 09.
Article in English | MEDLINE | ID: mdl-25517794

ABSTRACT

To obtain a satisfying anticancer effect, rationally designed nanocarriers are intensively studied. In this field, heparin and its derivatives have been widely attempted recently as potential component of nanocarriers due to their unique biological and physiochemical features, especially the anticancer activity. This review focuses on state-of-the-art nanocarriers with heparin/heparin derivatives as backbone or coating material. At the beginning, the unique advantages of heparin used in cancer nanotechnology are discussed. After that, different strategies of heparin chemical modification are reviewed, laying the foundation of developing various nanocarriers. Then a systematic summary of diverse nanoparticles with heparin as component is exhibited, involving heparin-drug conjugate, polymeric nanoparticles, nanogels, polyelectrolyte complex nanoparticles, and heparin-coated organic and inorganic nanoparticles. The application of these nanoparticles in various novel cancer therapy (containing targeted therapy, magnetic therapy, photodynamic therapy, and gene therapy) will be highlighted. Finally, future challenges and opportunities of heparin-based biomaterials in cancer nanotechnology are discussed.


Subject(s)
Disease Management , Drug Carriers/chemistry , Heparin/chemistry , Nanoparticles/chemistry , Neoplasms/drug therapy , Animals , Drug Carriers/administration & dosage , Drug Carriers/metabolism , Heparin/administration & dosage , Heparin/metabolism , Humans , Nanoparticles/administration & dosage , Nanoparticles/metabolism , Nanotechnology/methods , Nanotechnology/trends , Neoplasms/metabolism
11.
Br J Sports Med ; 49(13): 887-92, 2015 Jul.
Article in English | MEDLINE | ID: mdl-25833900

ABSTRACT

BACKGROUND: Antidoping and medical care delivery programmes are required at all large international multisport events. OBJECTIVE: To document and critique the novel antidoping and medical care delivery models implemented at the 2nd Summer Youth Olympic Games, Nanjing 2014. METHODS: The International Olympic Committee implemented two new models of delivery of antidoping and medical care at the YOG. A review of these models as well as the public health programme and two health educational initiatives in the Cultural and Educational Program was undertaken by the International Olympic Committee. RESULTS: The implementation of the new antidoping model was feasible in the setting of the YOG. The antidoping rules and regulations of the International Olympic Committee were respected. This model enhanced the educational initiative and provided financial as well as human resource savings. The execution of the hospital-based venue model of medical care delivery at the YOG was also feasible in this setting. This model provided a practical infrastructure for the delivery of medical care at multisport events with the goal of providing optimum athlete healthcare. A public health prevention programme was implemented and no public health risks were encountered by the participants or the Nanjing citizens during the YOG. Finally, the implementation of the athlete health educational programmes within the Cultural and Educational Program provided athletes with an opportunity to improve their health and performance. CONCLUSIONS: To achieve the goal of protecting athlete health, and of employing effective doping control and education, new alternate models of antidoping and medical care delivery can be implemented.


Subject(s)
Delivery of Health Care/methods , Doping in Sports/prevention & control , Substance Abuse Detection/methods , Youth Sports , Adolescent , Ambulatory Care/organization & administration , Athletes/education , Athletic Injuries/epidemiology , Athletic Injuries/prevention & control , China/epidemiology , Female , Health Education/methods , Humans , Male , Models, Theoretical , Public Health Administration/methods , Self Concept , Sex Offenses/prevention & control
12.
Int J Pharm ; 664: 124580, 2024 Oct 25.
Article in English | MEDLINE | ID: mdl-39142464

ABSTRACT

The tumor stroma plays a crucial role in tumor progression, and the interactions between the extracellular matrix, tumor cells, and stromal cells collectively influence tumor progression and the efficacy of therapeutic agents. Currently, utilizing components of the tumor stroma for drug delivery is a noteworthy strategy. A number of targeted drug delivery systems designed based on tumor stromal components are entering clinical trials. Therefore, this paper provides a thorough examination of the function of tumor stroma in the advancement of targeted drug delivery systems. One approach is to use tumor stromal components for targeted drug delivery, which includes certain stromal components possessing inherent targeting capabilities like HA, laminin, along with targeting stromal cells homologously. Another method entails directly focusing on tumor stromal components to reshape the tumor stroma and facilitate drug delivery. These drug delivery systems exhibit great potential in more effective cancer therapy strategies, such as precise targeting, enhanced penetration, improved safety profile, and biocompatibility. Ultimately, the deployment of these drug delivery systems can deepen our comprehension of tumor stroma and the advanced development of corresponding drug delivery systems.


Subject(s)
Antineoplastic Agents , Drug Delivery Systems , Neoplasms , Stromal Cells , Humans , Drug Delivery Systems/methods , Neoplasms/drug therapy , Animals , Stromal Cells/drug effects , Antineoplastic Agents/administration & dosage , Tumor Microenvironment/drug effects , Extracellular Matrix/metabolism
13.
Biomater Sci ; 12(2): 361-374, 2024 Jan 16.
Article in English | MEDLINE | ID: mdl-37982147

ABSTRACT

The eyes have a complicated microenvironment with many clearance mechanisms, making it challenging for effective drug delivery to the targeted areas of the eyes. Substrate transport mediated by active transporters is an important way to change drug metabolism in the ocular microenvironment. We designed multifunctional, dual-adaptive nanomicelles (GSCQ@NTB) which could overcome multiple physiological barriers by acting on both the efflux transporter and influx transporter to achieve deep delivery of the P-gp substrate in the cornea. Specifically, an effective "triple" antiangiogenic agent, nintedanib (NTB), was loaded into the biocompatible micelles. The expression of the efflux transporter was reversed by grafting quercetin. The peptide (glycylsarcosine, GS) was modified to target the influx transporter "Peptide Transporter-1" (PepT-1). Quercetin (QRT) and nintedanib (NTB) were transported to the cornea cooperatively, achieving long retention on the ocular surface and high compatibility. In a New Zealand rabbit model, within 8 hours after local administration, GSCQ@NTB was enriched in corneal stromal neovascularization and effectively inhibited the progress of neovascularization. Its effectiveness is slightly better than that in the first-line clinical application of steroids. In this study, we introduce the preparation of a dual adaptive nano-micelle system, which may provide an effective non-invasive treatment for corneal neovascularization.


Subject(s)
Cornea , Quercetin , Animals , Rabbits , Cornea/metabolism , Drug Delivery Systems , Micelles , Biological Transport, Active
14.
J Drug Target ; 32(2): 128-147, 2024 12.
Article in English | MEDLINE | ID: mdl-38217526

ABSTRACT

Atherosclerosis is one of the major causes of death worldwide, and it is closely related to many cardiovascular diseases, such as stroke, myocardial infraction and angina. Although traditional surgical and pharmacological interventions can effectively retard or slow down the progression of atherosclerosis, it is very difficult to prevent or even reverse this disease. In recent years, with the rapid development of nanotechnology, various nanoagents have been designed and applied to different diseases including atherosclerosis. The unique atherosclerotic microenvironment with signature biological components allows nanoplatforms to distinguish atherosclerotic lesions from normal tissue and to approach plaques specifically. Based on the process of atherosclerotic plaque formation, this review summarises the nanodrug delivery strategies for atherosclerotic therapy, trying to provide help for researchers to understand the existing atherosclerosis management approaches as well as challenges and to reasonably design anti-atherosclerotic nanoplatforms.


Subject(s)
Atherosclerosis , Plaque, Atherosclerotic , Humans , Atherosclerosis/drug therapy , Atherosclerosis/pathology , Plaque, Atherosclerotic/drug therapy , Plaque, Atherosclerotic/pathology , Drug Delivery Systems , Nanotechnology
15.
ACS Appl Mater Interfaces ; 16(3): 4071-4088, 2024 Jan 24.
Article in English | MEDLINE | ID: mdl-38194589

ABSTRACT

Surgical resection remains the most common method of tumor treatment; however, the high recurrence and metastasis after surgery need to be solved urgently. Herein, we report an injectable zwitterionic hydrogel based on "thiol-ene" click chemistry containing doxorubicin (DOX) and a macrophage membrane (MM)-coated 1-methyl-tryptophan (1-MT)-loaded polyamide-amine dendrimer (P-DOX/1MT) for preventing the postoperative recurrence of tumors. The results indicated that P-DOX/1MT@MM exhibited enhanced recognition and uptake of the dendrimer by tumor cells and induced the immunogenic cell death. In the mice tumor model, the P-DOX/1MT@MM-Gel exhibited high therapeutic efficiency, which could significantly reduce the recurrence of the tumor, including suppressing tumor growth, promoting dendritic cell maturation, and increasing tumor-infiltrating cytotoxic T lymphocytes. The mechanism analysis revealed that the hydrogel greatly reduces the side effects to normal tissues and significantly improves its therapeutic effect. 1MT in the hydrogel is released more rapidly, improving the tumor suppressor microenvironment and increasing the tumor cell sensitivity to DOX. Then, the DOX in the P-DOX/1MT@MM effectively eliminatedo the residual tumor cells and exerted enhanced toxicity. In conclusion, this novel injectable hydrogel that combines chemotherapy and immunotherapy has the property of sequential drug release and is a promising strategy for preventing the postoperative recurrence of tumors.


Subject(s)
Dendrimers , Neoplasms , Animals , Mice , Hydrogels/chemistry , Micelles , Dendrimers/pharmacology , Dendrimers/therapeutic use , Neoplasms/drug therapy , Doxorubicin/chemistry , Immunotherapy , Cell Line, Tumor , Tumor Microenvironment
16.
Curr Microbiol ; 66(6): 594-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23370734

ABSTRACT

The nematode-trapping fungus Arthrobotrys oligospora is able to produce extracellular protease that degrades the body walls of parasitic nematode larvae found in livestock and immobilizes the nematodes. Our aim was to obtain a strain of A. oligospora with a strong ability to trap nematodes by production of high levels of extracellular protease. A wild type strain of A. oligospora was subjected to mutagenic treatments involving low-energy ion beam implantation to generate mutants. Among these mutants, A. oligospora N showed high efficiency in trapping nematodes and was also able to secrete more extracellular protease, helping it to penetrate and digest the body walls of larvae. This work represents the first application of low-energy ion beams to generate mutations in a nematode-trapping fungus, and provides a new method of obtaining a fungus with high potential application.


Subject(s)
Ascomycota/genetics , Ascomycota/physiology , Mutagenesis , Nematoda/microbiology , Nematode Infections/veterinary , Peptide Hydrolases/metabolism , Sheep Diseases/therapy , Animals , Ascomycota/enzymology , Mutation , Nematode Infections/therapy , Peptide Hydrolases/genetics , Sheep/parasitology , Sheep Diseases/parasitology
17.
ACS Nano ; 17(12): 11537-11556, 2023 06 27.
Article in English | MEDLINE | ID: mdl-37272777

ABSTRACT

Ferroptosis activation has been considered a mighty weapon for cancer treatment, and growing attention is being paid to reinforcing tumor cells' sensitivity to ferroptosis. However, the existence of certain ferroptosis resistance mechanisms, especially the abnormal metabolism of tumor cells, has long been underestimated. We propose an enhanced ferroptosis-activating pattern via regulating tumor cells' glycometabolism and construct a nanoplatform named PMVL, which is composed of lonidamine (LND)-loaded tannic acid coordinated vanadium oxides with the camouflage of PD-L1 inhibiting peptide-modified tumor cell membrane. This work reveals that the mixed valence of vanadium (VIV and VV) in PMVL triggers ferroptosis due to the self-cyclic valence alteration of V, the process of which generates •OH for lipid peroxide accumulation (VIV → VV) and depletes glutathione (GSH) for glutathione peroxidase (GPX4) deactivation (VV → VIV). Notably, LND strengthens ferroptosis by dual suppression of glycolysis (decreasing ATP supply) and the pentose phosphate pathway (decreasing NADPH production), causing anabatic GSH consumption. Besides, the inhibited glycolysis generates less intracellular lactic acid and alleviates the acidity of tumor microenvironment, preventing immunosuppressive M2 macrophage polarization. In vitro and in vivo data demonstrate the glycometabolism-intervention-enhanced ferroptosis and boosted immunity activation, potentially providing opportunities and possibilities for synergetic cancer therapy.


Subject(s)
Neoplasms , Vanadium , Humans , Neoplasms/drug therapy , Neoplasms/metabolism , Cell Death , Glutathione Peroxidase/metabolism , Glucose , Cell Line, Tumor , Tumor Microenvironment
18.
Int J Pharm ; 641: 123069, 2023 Jun 25.
Article in English | MEDLINE | ID: mdl-37225024

ABSTRACT

The application of variable novel drug delivery system has shown a flowering trend in recent years. Among them, the cell-based drug delivery system (DDS) utilizes the unique physiological function of cells to deliver drugs to the lesion area, which is the most complex and intelligent DDS at present. Compared with the traditional DDS, the cell-based DDS has the potential of prolonged circulation in body. Cellular DDS is expected to be the best carrier to realize multifunctional drug delivery. This paper introduces and analyzes common cellular DDSs such as blood cells, immune cells, stem cells, tumor cells and bacteria as well as relevant research examples in recent years. We hope that this review can provide a reference for future research on cell vectors and promote the innovative development and clinical transformation of cell-based DDS.


Subject(s)
Drug Delivery Systems
19.
J Drug Target ; 31(4): 335-353, 2023 04.
Article in English | MEDLINE | ID: mdl-36543743

ABSTRACT

Extracellular vesicles (EVs) could be produced by most cells and play an important role in disease development. As a subtype of EVs, exosomes exhibit suitable size, rich surface markers and diverse contents, making them more appealing as potential drug carriers. Compared with traditional synthetic nanoparticles, exosomes possess superior biocompatibility and much lower immunogenicity. This work reviewed the most up-to-date research progress of exosomes as carriers for nucleic acids, proteins and small molecule drugs for cancer and inflammation management. The drug loading strategies and potential cellular uptake behaviour of exosomes are highlighted, trying to provide reference for future exosome design and application.


Exosomes are secreted by a variety of cells and play an important role in the process of inter-cell communication.This paper provides a comprehensive review focussing on the up-to-date applications of exosomes as carriers of nucleic acids, proteins and small molecule drugs for cancer and inflammation management.This paper briefly introduces the basic properties of exosomes, from definition, biogenesis to cellular uptake manners.Various strategies to enable exosomes to efficiently load cargoes are highlighted.Problems to be solved when using exosomes to deliver drugs are discussed.


Subject(s)
Exosomes , Extracellular Vesicles , Neoplasms , Humans , Drug Carriers/metabolism , Exosomes/metabolism , Neoplasms/drug therapy , Neoplasms/metabolism , Drug Delivery Systems
20.
Animals (Basel) ; 13(5)2023 Mar 03.
Article in English | MEDLINE | ID: mdl-36899776

ABSTRACT

A major problem faced by the agricultural industry is the resistance of Haemonchus contortus to anthelmintic drugs. For a better understanding of the response of H. contortus to IVM and for the screening of drug-resistance-related genes, we used RNA sequencing and isobaric tags for relative and absolute quantification (iTRAQ) technology to detect the transcriptomic and proteomic changes in H. contortus after ivermectin treatment. An integrated analysis of the two omics showed that the differentially expressed genes and proteins were significantly enriched in the pathways of amino acid degradation, the metabolism of xenobiotics by cytochrome P450, the biosynthesis of amino acids, and the tricarboxylic acid cycle. We found that the upregulated UDP-glycosyltransferases (UGT), glutathione S-transferase (GST), cytochrome P450 (CYP), and p-glycoprotein (Pgp) genes play important roles in drug resistance in H. contortus. Our work will help in the understanding of the transcriptome and proteome changes in H. contortus after IVM and will facilitate the discovery of genes related to drug resistance. This information can be further applied to increase the understanding of the response of IVM in relation to H. contortus.

SELECTION OF CITATIONS
SEARCH DETAIL